Related Experiment Video

Updated: Apr 8, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.7K

HCV Treatments and Their Integration Into Rheumatology

Dimitrios Vassilopoulos1, Leonard H Calabrese

  • 1School of Medicine, 2nd Department of Medicine, Hippokration General Hospital, Athens University, 114 Vass. Sophias Ave., 115 27, Athens, Greece, dvassilop@med.uoa.gr.

Current Rheumatology Reports
|June 27, 2015
PubMed

Insights

Hepatitis C virus (HCV)-associated rheumatic diseases show improved outcomes with new direct-acting antivirals (DAAs). These IFN-free regimens achieve high viral clearance rates, offering better treatment options for patients.

Area of Science:

  • Rheumatology
  • Hepatology
  • Virology

Background:

  • Hepatitis C virus (HCV) is linked to rheumatic conditions like arthritis, sialadenitis, and cryoglobulinemic vasculitis (CV).
  • Current treatments involve antiviral therapy, sometimes with immunosuppressants, with response tied to viral clearance.
  • Interferon-alpha (IFNα)-based therapies achieve viral eradication in only about half of patients.

Purpose of the Study:

  • To review current therapeutic strategies for HCV-associated rheumatic syndromes.
  • To evaluate the role of novel direct-acting antivirals (DAAs) in managing these conditions.

Main Methods:

  • Review of current literature on HCV-associated rheumatic syndromes.
  • Analysis of the efficacy of interferon-free regimens using direct-acting antivirals (DAAs).

Main Results:

  • Direct-acting antivirals (DAAs) offer short-term, IFN-free treatment regimens.
  • These new regimens achieve viral clearance in over 90% of treated patients.
  • Clinical response in HCV-associated rheumatic syndromes is strongly correlated with viral eradication.

Conclusions:

  • Direct-acting antivirals (DAAs) represent a significant advancement in treating HCV-associated rheumatic syndromes.
  • IFN-free DAA regimens provide a highly effective option for viral clearance.
  • An integrated therapeutic approach incorporating DAAs is recommended for managing these complex conditions.

More Related Videos

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

1.4K
A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.8K

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
46
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
511
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
457
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.7K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.1K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
904